Form 4: IN8BIO Director Emily Fairbairn Acquires Stock Options

Director Emily Fairbairn acquired stock options in IN8BIO, INC. on May 8, 2025.

Summary

• On May 8, 2025, Emily Fairbairn, a director of IN8BIO, INC., acquired stock options to purchase 63,150 shares of common stock at an exercise price of $0.17 per share.
• The options vest in equal monthly installments starting June 8, 2025, with full vesting by the date of the company's next annual meeting of stockholders, contingent on continued service.
• Following the transaction, Fairbairn directly owns options for 63,150 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock option grants to a director. It indicates alignment of interest but doesn't necessarily imply a significant positive or negative outlook.

Positives

• The acquisition of stock options by a director signals confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of stock options by a director can align their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

Keywords

IN8BIO, stock options, director, Emily Fairbairn, beneficial ownership, Form 4, acquisition